David Zurakowski
Overview
Explore the profile of David Zurakowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
969
Citations
16418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Operative and nonoperative outcomes in patients with trisomy 13 and 18 with congenital heart disease
Greene C, Schulz A, Chavez M, Staffa S, Zurakowski D, Friedman K, et al.
JTCVS Open
. 2024 Sep;
20:123-131.
PMID: 39296445
Objective: To evaluate the short- and long-term outcomes of cardiac repair versus nonoperative management in patients with trisomy 13 and trisomy 18 with congenital heart disease. Methods: An institutional review...
12.
Whitlock A, Moskowitzova K, Kycia I, Nelson J, Zurakowski D, Fauza D
Fetal Diagn Ther
. 2024 Sep;
:1-8.
PMID: 39265555
Introduction: Secretory immunoglobulin-A (SIgA), which is not produced perinatally, binds bacteria enhancing mucosal immunity. Higher levels of intestinal bacteria bound by SIgA are protective against necrotizing enterocolitis. Transamniotic fetal immunotherapy...
13.
Moskowitzova K, Naus A, Dang T, Zurakowski D, Fauza D
Fetal Diagn Ther
. 2024 Sep;
:1-7.
PMID: 39265536
Introduction: We sought to determine whether exogenous surfactant protein B (SPB) mRNA could be incorporated and translated by the fetal lung after simple transamniotic administration. Methods: Fetuses (n = 149)...
14.
Staffa S, Stanek K, Nasr V, Zurakowski D
J Thorac Cardiovasc Surg
. 2024 Sep;
169(3):943-951.e15.
PMID: 39243960
Background: The use of machine learning (ML) in cardiovascular and thoracic surgery is evolving rapidly. Maximizing the capabilities of ML can help improve patient risk stratification and clinical decision making,...
15.
Martin A, Zhang S, Williamson A, Tingley B, Pickus M, Zurakowski D, et al.
bioRxiv
. 2024 Sep;
PMID: 39229224
Image analysis of subcellular structures and biological processes relies on specific, context-dependent pipelines, which are labor-intensive, constrained by the intricacies of the specific biological system, and inaccessible to broader applications....
16.
Diaz-Gil D, Silva-Gomez N, Morton S, Seidman J, Seidman C, Zurakowski D, et al.
J Thorac Cardiovasc Surg
. 2024 Aug;
169(2):366-374.
PMID: 39208926
Background: Endocardial fibroelastosis (EFE) is a major effector in the maldevelopment of the heart in patients with congenital heart disease. Despite successful surgical removal, EFE can redevelop, but the underlying...
17.
Lang N, Staffa S, Zurakowski D, Sperotto F, Shea M, Baird C, et al.
JACC Adv
. 2024 Aug;
3(8):101081.
PMID: 39113914
Background: Congenital mitral valve disease (CMVD) presents major challenges in its medical and surgical management. Objectives: The purpose of this study was to investigate the value of 3-dimensional echocardiography (3DE)...
18.
Cattapan C, Jacobs J, Bleiweis M, Sarris G, Tobota Z, Guariento A, et al.
Ann Thorac Surg
. 2024 Aug;
PMID: 39102931
Background: We evaluated outcomes of neonatal cardiac surgery at hospitals affiliated with the European Congenital Heart Surgeons Association (ECHSA). Methods: All patients ≤30 days of life undergoing a cardiac surgical...
19.
Smith T, DeYoung J, Pum J, Zurakowski D, Templeton K, Day C
J Am Acad Orthop Surg
. 2024 Jul;
32(21):1003-1010.
PMID: 39018573
Background: Despite widespread acceptance of the importance of diversity in leadership, systemic challenges in leadership attainment in orthopaedic surgery still exist for several groups. We hypothesize that women, underrepresented in...
20.
Kobayashi K, Kobayashi K, Liu C, Ryan J, Zurakowski D, Ishibashi N
Pediatr Cardiol
. 2024 Jun;
PMID: 38918239
Phase 1 trials are primarily conducted to evaluate the safety and feasibility of new interventions, usually without recruiting control patients. This retrospective study aims to characterize clinical and biological outcomes...